A Novel Orally Bioavailable Inhibitor of Kinase Insert Domain-Containing Receptor Induces Antiangiogenic Effects and Prevents Tumor Growth <b> <i>in Vivo</i> </b>Laura Sepp‐Lorenzino, Kenneth A. Thomas, Jennifer M. Shipman et al.|Cancer Research|2004Cited by 26
Novel Flt-3/KDR inhibitor is effective against activated Flt-3 and is cytotoxic against Flt-3-driven leukemias in vitro and in vivoStephen C. Beck, Laura Sepp‐Lorenzino, Lenora J. Davis et al.|Cancer Research|2004Cited by 0